Assessment of Minimal Residual Disease in Ewing Sarcoma

Por Wagner, Lars M., Smolarek, Teresa A., Sumegi, Janos, Marmer, Daniel
Publicado em 2012

Copy number variation as a genetic basis for heterotaxy and heterotaxy-spectrum congenital heart defects

Por Cowan, Jason R., Tariq, Muhammad, Shaw, Chad, Rao, Mitchell, Belmont, John W., Lalani, Seema R., Smolarek, Teresa A., Ware, Stephanie M.
Publicado no Philos Trans R Soc Lond B Biol Sci (2016)

Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280014 and Trastuzumab (Herceptin(®))

Por Hurst, Susan, Ryan, Anne M., Ng, Chee-Keng, McNally, James M., Lorello, Leslie G., Finch, Gregory L., Leach, Michael W., Ploch, Stephen A., Fohey, Josh A., Smolarek, Teresa A.
Publicado em 2014

Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade(®) (Infliximab)

Por Derzi, Mazin, Johnson, Theodore R., Shoieb, Ahmed M., Conlon, Hugh D., Sharpe, Penny, Saati, Andrew, Koob, Sarah, Bolt, Michael W., Lorello, Leslie G., McNally, Jim, Kirchhoff, Carol F., Smolarek, Teresa A., Leach, Michael W.
Publicado no Adv Ther (2016)

Redefined genomic architecture in 15q24 directed by patient deletion/duplication breakpoint mapping

Por El-Hattab, Ayman W., Smolarek, Teresa A., Walker, Martha E., Schorry, Elizabeth K., Immken, LaDonna L., Patel, Gayle, Abbott, Mary-Alice, Lanpher, Brendan C., Ou, Zhishuo, Kang, Sung-Hae L., Patel, Ankita, Scaglia, Fernando, Lupski, James R., Cheung, Sau Wai, Stankiewicz, Pawel
Publicado em 2009